Differential response to radiation of TP53-inactivated cells by overexpression of dominant-negative mutant TP53 or HPVE6

Radiation Research

Volumn 161, Issue 5, 2004, Pages 504-510

  Franken, N A P ^a   Van Bree, C ^a   Haveman, J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; PROTEIN P21; PROTEIN P53; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; RECOMBINANT PROTEIN; REPRESSOR PROTEIN;

ARTICLE; CELL CYCLE G1 PHASE; CELL DAMAGE; CELL JUNCTION; CELL SURVIVAL; CONTROLLED STUDY; GENE INACTIVATION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE E6; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RADIATION RESPONSE; RADIOSENSITIVITY; TUMOR SUPPRESSOR GENE; WART VIRUS; CHROMOSOME ABERRATION; COLORECTAL TUMOR; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HUMAN CHROMOSOME; METABOLISM; METAPHASE; MUTATION; PATHOLOGY; RADIATION DOSE; RADIATION EXPOSURE;

CELL SURVIVAL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; COLORECTAL NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, RADIATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; METAPHASE; MUTATION; ONCOGENE PROTEINS, VIRAL; RADIATION DOSAGE; RECOMBINANT PROTEINS; REPRESSOR PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 2942607911     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3160     Document Type: Article

References (36)

1. S. J. Kuerbitz, B. S. Plunkett, W. V. Walsh and M. B. Kastan, Wildtype p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA 89, 7491-7495 (1992).
2. M. B. Kastan, O. Onyekwere, D. Sidransky, B. Vogelstein and R. W. Craig, Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51, 6304-6311 (1991).
3. 1 arrest involves pRb-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc. Natl. Acad. Sci. USA 91, 5320-5324 (1994).
4. A. V. Gudkov and E. A. Komarova, The role of p53 in determining sensitivity to radiotherapy. Nat. Rev. Cancer 3, 117-129 (2003).
5. 2 delay. Cancer Res. 55, 1643-1648 (1995).
6. D. A. Haas-Kogan, S. S. Kogan, G. Yount, J. Hsu, M. Haas, D. F. Deen and M. A. Israel, p53 function influences the effect of fractionated radiotherapy on glioblastoma tumors. Int. J. Radiat. Oncol. Biol. Phys. 43, 399-403 (1999).
7. J. C. Ribeiro, A. R. Barnetson, R. J. Fisher, H. Mameghan and P. J. Russell, Relationship between radiation response and p53 status in human bladder cancer cells. Int. J. Radiat. Biol. 72, 11-20 (1997).
8. N. A. P. Franken, C. van Bree, R. ten Cate, C. H. van Oven and J. Haveman, Importance of TP53 and RB in the repair of potentially lethal damage and induction of color junctions after exposure to ionizing radiation. Radiat. Res. 158, 707-714 (2002).
9. T. D. Kessis, R. J. Slebos, W. G. Nelson, M. B. Kastan, B. S. Plunkett, S. M. Man, A. T. Lorincz, L. Hedrick and K. R. Cho, Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc. Natl. Acad. Sci. USA 90, 3988-3992 (1993).
10. S. M. Morris, A role for p53 in the frequency and mechanism of , mutation. Mutat. Res. 511, 45-62 (2002).
11. J. L. Schwartz, J. Rasey, L. Wiens, R. Jordan and K. J. Russell, Functional inactivation of p53 by HPV-E6 transformation is associated with a reduced expression of radiation-induced potentially lethal damage. Int. J. Radiat. Biol. 75, 285-291 (1999).
12. C. van Bree, B. van der Maat, H. M. Ceha, N. A. P. Franken, J. Haveman and P. J. Bakker, Inactivation of p53 and of pRb protects human colorectal carcinoma cells against hyperthermia-induced cytotoxicity and apoptosis. J. Cancer Res. Clin. Oncol. 125, 549-555 (1999).
13. C. E. Ng, S. K. Banerjee, M. Pavliv, G. Wang, G. P. Raaphorst and R. A. Aubin, p53 status, cellular recovery and cell cycle arrest as prognosticators of in vitro radiosensitivity in human pancreatic adenocarcinoma cell lines. Int. J. Radiat. Biol. 75, 1365-1376 (1999).
14. J. L. Schwartz, R. Jordan, W. K. Kaufmann, J. Rasey, K. J. Russell and R. R. Weichselbaum, Evidence for the expression of radiation-induced potentially lethal damage being a p53-dependent process. Int. J. Radiat. Biol. 76, 1037-1043 (2000).
15. 1 checkpoint does not decrease cell survival following DNA damage. Cancer Res. 53, 4164-4168 (1993).
16. 1-phase checkpoint. Radiat. Res. 145, 289-298 (1996).
17. C. van Bree, J. H. Savonije, N. A. P. Franken, J. Haveman and P. J. Bakker, The effect of p53-function on the sensitivity to paclitaxel with or without hyperthermia in human colorectal carcinoma cells. Int. J. Oncol. 16, 739-744 (2000).
18. C. van Bree, N. A. P. Franken, F. A. Snel, J. Haveman and P. J. Bakker, Wild-type p53-function is not required for hyperthermia-enhanced cytotoxicity of cisplatin. Int. J. Hyperthermia 17, 337-346 (2001).
19. S. Fan, M. L. Smith, D. J. Rivet, 2nd, D. Duba, Q. Zhan, K. W. Kohn, A. J. Fornace, Jr. and P. M. O'Connor, Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Res. 55, 1649-1654 (1995).
20. G. W. Barendsen, Parameters of linear-quadratic radiation dose-effect relationships: Dependence on LET and mechanisms of reproductive cell death. Int. J. Radiat. Biol. 71, 649-655 (1997).
21. A. T. Natarajan, R. C. Vyas, F. Darroudi and S. Vermeulen, Frequencies of X-ray-induced chromosome translocations in human peripheral lymphocytes as detected by in situ hybridization using chromosome-specific DNA libraries. Int. J. Radiat. Biol. 61, 199-203 (1992).
22. N. Castro Kreder, C. van Bree, N. A. P. Franken and J. Haveman, Predictive value of FISH: Correlation between cell survival and chromosomal aberrations after high dose rate and pulsed low dose rate irradiation. Int. J. Radiat Biol. 78, 203-210 (2002).
23. H. Caron, B. Van Schaik, M. Van Der Mee, F. Baas, G. Riggins, P. Van Sluis, M-C. Hermus, R. Van Asperen, K. Boon and R. Versteeg, The human transcriptome map: Clustering of highly expressed genes in chromosomal domains. Science 291, 1289-1293 (2001).
24. J. D. Tucker, W. F. Morgan, A. A. Awa, M. Bauchinger, D. Blakey, M. N. Cornforth, L. G. Littlefield, A. T. Natarajan and C. Shasserre, A proposed system for structural aberrations detected by chromosome painting. Cytogenet. Cell Genet. 68, 211-221 (1995).
25. 2/M accumulation. Int. J. Radiat. Oncol. Biol. Phys. 44, 1119-1124 (1999).
26. T. Ohnishi, K. Ohnishi and A. Takahashi, Glycerol restores heat-induced p53-dependent apoptosis of human glioblastoma cells bearing mutant p53. BMC Biotechnol. 2, 6 (2002). [www.biomedcentral.com/1472-6750/2/6]
27. S. P. Linke, K. C. Clarkin and G. M. Wahl, P53 mediates permanent arrest over multiple cell cycles in response to γ-irradiation. Cancer Res. 57, 1171-1179 (1997).
28. M. Akashi, M. Hachiya, Y. Osawa, K. Spirin, G. Suzuki and H. P. Koeffler, Irradiation induces WAF1 expression through a p53-independent pathway in KG-1 cells. J. Biol. Chem. 270, 19181-19187 (1995).
29. B. Jakob, M. Scholz and G. Taucher-Scholz, Characterization of CDKN1A (p21) binding to sites of heavy-ion-induced damage: Colocalization with proteins involved in DNA repair. Int. J. Radiat. Biol. 78, 75-88 (2002).
30. M. M. Ahmed, K. Venkatasubbarao, S. M. Fruitwala, S. Muthukkumar, D. P. Wood, Jr., S. F. Sells, M. Mohiuddin and V. M. Rangnekar, EGR-1 induction is required for maximal radiosensitivity in A375-C6 melanoma cells. J. Biol. Chem. 271, 29231-29237 (1996).
31. D. Dittmer, S. Pati, G. Zambetti, S. Chu, A. K. Teresky, M. Moore, C. Finlay and A. J. Levine, Gain of mutations in p53. Nat. Genet. 4, 42-45 (1993).
32. R. G. Bristow, Q. Hu, A. Jang, S. Chung, J. Peacock, S. Benchimol and R. Hill, Radioresistant MTp53-expressing rat embryo cell transformants exhibit increased DNA-dsb rejoining during exposure to ionizing radiation. Oncogene 16, 1789-1802 (1998).
33. R. G. Bristow, J. Peacock, A. Jang, J. Kim, R. P. Hill and S. Benchimol, Resistance to DNA-damaging agents is discordant from experimental metastatic capacity in MEF ras-transformants-expressing gain of function MTp53. Oncogene 22, 2960-2966 (2003).
34. N. A. P. Franken, P. Ruurs, G. Ludwikow, C. van Bree, J. B. Kipp, F. Darroudi and G. W. Barendsen, Correlation between cell reproductive death and chromosome aberrations assessed by FISH for low and high doses of radiation and sensitization by iodo-deoxyuridine in human SW-1573 cells. Int. J. Radiat. Biol. 75, 293-299 (1999).
35. N. A. P. Franken, C. van Bree, M. A. T. Veltmaat, G. Ludwikow, J. B. A. Kipp and G. W. Barendsen, Increased chromosome exchange frequencies in iodo-deoxyuridine-sensitized human SW-173 cells after γ-irradiation. Oncol. Rep. 6, 59-63 (1999).
36. J. Coco-Martin, E. Mooren, C. Ottenheim, W. Burrill, M. I. Nunez, D. Sprong, H. Bartelink and A. C. Begg, Potential of radiation-induced chromosome aberrations to predict radiosensitivity in human tumour cells. Int. J. Radiat. Biol. 75, 1161-1168 (1999).